Gilead outlines plans to distribute COVID-19 drug worldwide
Gilead on Tuesday said it is negotiating with overseas drug manufacturers to license its SBECD-enabled coronavirus treatment remdesivir in an effort
A forum for researchers, students and applicants in the field of cyclodextrin technology
Gilead on Tuesday said it is negotiating with overseas drug manufacturers to license its SBECD-enabled coronavirus treatment remdesivir in an effort
A recent review [1] on the copolymers of beta-cyclodextrin with 192 references can be useful for those who want to
The 9th Annual International Symposium of Drug Delivery Systems – 2020 (SDDS-2020) which will was originally planned during July 15-17,
A Gilead Sciences, Inc. amerikai gyógyszercég tegnap bejelentette, hogy a U.S. Food and Drug Administration (FDA, amerikai gyógyszerhatóság) úgynevezett “emergency
Gilead Sciences, Inc. yesterday announced that the U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for
New virtual event format for the 2020 BIO International Convention will be introduced on June 8-12, 2020. BIO is committed
Gilead Sciences today announced that preliminary results of a coronavirus drug trial showed at least 50% of patients treated with
Dental Tribune, the European blog of dentists published a post on the possible application of cyclodextrins as a mouth rinse
Prime Minister Shinzo Abe said Monday that Japan will soon approve the SBECD-eanbled anti-viral drug remdesivir for the treatment of
A Chinese group has recently published [1] their interesting findings: in atherosclerosis β-CD (probaly methyl beta-cyclodextrin, but not specified) was